Scientific paper - Original scientific paper
Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant
BMC Medicine, 20 (2022), 1; 102. https://doi.org/10.1186/s12916-022-02312-5

Schubert, Maren; Bertoglio, Federico; Steinke, Stephan; Heine, Philip Alexander; Ynga-Durand, Mario Alberto; Maass, Henrike; Sammartino, Josè Camilla; Cassaniti, Irene; Zuo, Fanglei; Du, Likun; Korn, Janin; Milošević, Marko; Wenzel, Esther Veronika; Krstanović, Fran; Polten, Saskia; Pribanić-Matešić, Marina; Brizić, Ilija; Baldanti, Fausto; Hammarström, Lennart; Dübel, Stefan; Šustić, Alan; Marcotte, Harold; Strengert, Monika; Protić, Alen; Piralla, Antonio; Pan-Hammarström, Qiang; Čičin-Šain, Luka; Hust, Michael More authors...

Linked objects
COVID-19 | Virtual collection
Cite this document

Schubert, M., Bertoglio, F., Steinke, S., Heine, P. A., Ynga Durand, M. A., Maass, H. ... Hust, M. (2022). Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant. BMC Medicine, 20. (1). doi: 10.1186/s12916-022-02312-5

Schubert, Maren, et al. "Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant." BMC Medicine, vol. 20, no. 1, 2022. https://doi.org/10.1186/s12916-022-02312-5

Schubert, Maren, Federico Bertoglio, Stephan Steinke, Philip Alexander Heine, Mario Alberto Ynga Durand, Henrike Maass, Josè Camilla Sammartino, et al. "Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant." BMC Medicine 20, no. 1 (2022). https://doi.org/10.1186/s12916-022-02312-5

Schubert, M., et al. (2022) 'Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant', BMC Medicine, 20(1). doi: 10.1186/s12916-022-02312-5

Schubert M, Bertoglio F, Steinke S, Heine PA, Ynga Durand MA, Maass H, and sur.. Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant. BMC Medicine [Internet]. 2022 March 03 [cited 2024 October 01];20(1). doi: 10.1186/s12916-022-02312-5

M. Schubert, et al., "Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant", BMC Medicine, vol. 20, no. 1, March 2022. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:201199. [Accessed: 01 October 2024]

Please login to the repository to save this object to your list.